Pakistan, July 25 -- Pakistan has moved a step closer to making dozens of new life-saving medicines available after a federal cabinet subcommittee approved the prices of 52 newly registered drugs.

Read More: PM vows fool-proof security for Chinese nationals in Pakistan

The meeting, chaired by Finance Minister Muhammad Aurangzeb, was attended by Health Minister Mustafa Kamal, senior health officials and representatives of the Drug Regulatory Authority of Pakistan (DRAP).

The approved medicines include treatments for cancer, diabetes, haemophilia and Parkinson's disease. Among them is Keytruda (pembrolizumab), a modern immunotherapy drug used worldwide to treat more than 20 types of cancer. Other approved medicines include nivolumab, das...